175 related articles for article (PubMed ID: 28240188)
1. Parkinson's Disease is Accompanied by Intertwined Alterations in Iron Metabolism and Activated Immune-inflammatory and Oxidative Stress Pathways.
de Farias CC; Maes M; Bonifacio KL; Matsumoto AK; Bortolasci CC; Nogueira AS; Brinholi FF; Morimoto HK; de Melo LB; Moreira EG; Barbosa DS
CNS Neurol Disord Drug Targets; 2017; 16(4):484-491. PubMed ID: 28240188
[TBL] [Abstract][Full Text] [Related]
2. Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.
Medeiros MS; Schumacher-Schuh A; Cardoso AM; Bochi GV; Baldissarelli J; Kegler A; Santana D; Chaves CM; Schetinger MR; Moresco RN; Rieder CR; Fighera MR
PLoS One; 2016; 11(1):e0146129. PubMed ID: 26751079
[TBL] [Abstract][Full Text] [Related]
3. Hyperferritinemia and markers of inflammation and oxidative stress in the cord blood of HIV-exposed, uninfected (HEU) infants.
Selvam A; Buhimschi IA; Makin JD; Pattinson RC; Anderson R; Forsyth BW
HIV Med; 2015 Jul; 16(6):375-80. PubMed ID: 25721379
[TBL] [Abstract][Full Text] [Related]
4. Lower hemoglobin levels in patients with parkinson's disease are associated with disease severity and iron metabolism.
Deng Q; Zhou X; Chen J; Pan M; Gao H; Zhou J; Wang D; Chen Q; Zhang X; Wang Q; Xu Y
Brain Res; 2017 Jan; 1655():145-151. PubMed ID: 27840188
[TBL] [Abstract][Full Text] [Related]
5. Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression.
Ikeda K; Nakamura Y; Kiyozuka T; Aoyagi J; Hirayama T; Nagata R; Ito H; Iwamoto K; Murata K; Yoshii Y; Kawabe K; Iwasaki Y
Neurodegener Dis; 2011; 8(4):252-8. PubMed ID: 21282940
[TBL] [Abstract][Full Text] [Related]
6. [Case-control study of markers of oxidative stress and metabolism of blood iron in Parkinson's disease].
Larumbe Ilundáin R; Ferrer Valls JV; Viñes Rueda JJ; Guerrero D; Fraile P
Rev Esp Salud Publica; 2001; 75(1):43-53. PubMed ID: 11400414
[TBL] [Abstract][Full Text] [Related]
7. Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson's disease and its progression: Disease and staging biomarkers and new drug targets.
de Farias CC; Maes M; Bonifácio KL; Bortolasci CC; de Souza Nogueira A; Brinholi FF; Matsumoto AK; do Nascimento MA; de Melo LB; Nixdorf SL; Lavado EL; Moreira EG; Barbosa DS
Neurosci Lett; 2016 Mar; 617():66-71. PubMed ID: 26861200
[TBL] [Abstract][Full Text] [Related]
8. Correlations between abnormal iron metabolism and non-motor symptoms in Parkinson's disease.
Xu W; Zhi Y; Yuan Y; Zhang B; Shen Y; Zhang H; Zhang K; Xu Y
J Neural Transm (Vienna); 2018 Jul; 125(7):1027-1032. PubMed ID: 29748849
[TBL] [Abstract][Full Text] [Related]
9. Plasma transferrin level correlates with the tremor-dominant phenotype of Parkinson's disease.
Si QQ; Yuan YS; Zhi Y; Tong Q; Zhang L; Zhang K
Neurosci Lett; 2018 Sep; 684():42-46. PubMed ID: 29981876
[TBL] [Abstract][Full Text] [Related]
10. Serum glutathione peroxidase, xanthine oxidase, and superoxide dismutase activities and malondialdehyde levels in patients with Parkinson's disease.
Gökçe Çokal B; Yurtdaş M; Keskin Güler S; Güneş HN; Ataç Uçar C; Aytaç B; Durak ZE; Yoldaş TK; Durak İ; Çubukçu HC
Neurol Sci; 2017 Mar; 38(3):425-431. PubMed ID: 27900485
[TBL] [Abstract][Full Text] [Related]
11. Smoking and haptoglobin phenotype modulate serum ferritin and haptoglobin levels in Parkinson disease.
Costa-Mallen P; Zabetian CP; Hu SC; Agarwal P; Yearout D; Checkoway H
J Neural Transm (Vienna); 2016 Nov; 123(11):1319-1330. PubMed ID: 27349967
[TBL] [Abstract][Full Text] [Related]
12. Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson's disease.
Andican G; Konukoglu D; Bozluolcay M; Bayülkem K; Firtiına S; Burcak G
Acta Neurol Belg; 2012 Jun; 112(2):155-9. PubMed ID: 22426659
[TBL] [Abstract][Full Text] [Related]
13. Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson's and Alzheimer's Diseases.
Boyko AA; Troyanova NI; Kovalenko EI; Sapozhnikov AM
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29211044
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and aminopeptidases in Parkinson's disease patients with and without treatment.
Duran R; Barrero FJ; Morales B; Luna JD; Ramirez M; Vives F
Neurodegener Dis; 2011; 8(3):109-16. PubMed ID: 20714110
[TBL] [Abstract][Full Text] [Related]
15. Peripheral iron metabolism in patients with Parkinson's disease.
Cabrera-Valdivia F; Jiménez-Jiménez FJ; Molina JA; Férnandez-Calle P; Vázquez A; Cañizares-Liébana F; Larumbe-Lobalde S; Ayuso-Peralta L; Rabasa M; Codoceo R
J Neurol Sci; 1994 Aug; 125(1):82-6. PubMed ID: 7964893
[TBL] [Abstract][Full Text] [Related]
16. Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease.
Chen CM; Liu JL; Wu YR; Chen YC; Cheng HS; Cheng ML; Chiu DT
Neurobiol Dis; 2009 Mar; 33(3):429-35. PubMed ID: 19110057
[TBL] [Abstract][Full Text] [Related]
17. [Metals and oxidative stress in Parkinson's disease from industrial areas with exposition to environmental toxins or metal pollution].
Squitti R; Gorgone G; Binetti G; Ghidoni R; Pasqualetti P; Draicchio F; Albini E; Benedetti L; Lucchini R; Rossini PM
G Ital Med Lav Ergon; 2007; 29(3 Suppl):294-6. PubMed ID: 18409692
[TBL] [Abstract][Full Text] [Related]
18. The relation of serum uric acid levels with L-Dopa treatment and progression in patients with Parkinson's disease.
Vieru E; Köksal A; Mutluay B; Dirican AC; Altunkaynak Y; Baybas S
Neurol Sci; 2016 May; 37(5):743-7. PubMed ID: 26753800
[TBL] [Abstract][Full Text] [Related]
19. Association of Parkinson's disease with altered serum levels of lead and transition metals among South Indian subjects.
Kumudini N; Uma A; Devi YP; Naushad SM; Mridula R; Borgohain R; Kutala VK
Indian J Biochem Biophys; 2014 Apr; 51(2):121-6. PubMed ID: 24980015
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and clinical effects of Whey protein supplementation in Parkinson's disease: A pilot study.
Tosukhowong P; Boonla C; Dissayabutra T; Kaewwilai L; Muensri S; Chotipanich C; Joutsa J; Rinne J; Bhidayasiri R
J Neurol Sci; 2016 Aug; 367():162-70. PubMed ID: 27423583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
